LONGBOARD PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.72 USD | +2.44% |
|
+13.07% | +227.03% |
Chart calendar Longboard Pharmaceuticals, Inc.
e7.oU59a9uwiPFhOka6gM68oGxmD_Wh_3yFIPPnlwhTW1o.8jklOo6Jvr8XayuP8ILVxToMV7bbtBrAdLGopnkhESDNIS8ErPLQnQJwcg~8b7c8384e3bad35f368f4c46d6d4f5fc
Upcoming events on Longboard Pharmaceuticals, Inc.
Past events on Longboard Pharmaceuticals, Inc.
| 13/03/2024 01:31 am | Q4 2023 Earnings Release |
| 15/02/2024 01:50 am | Oppenheimer Healthcare Life Sciences Conference |
| 07/02/2024 11:30 pm | Guggenheim Healthcare Talks Biotechnology Conference |
| 02/01/2024 07:00 pm | PACIFIC Phase 1b/2a Clinical Trial Results Call |
| 05/12/2023 12:30 am | American Epilepsy Society Meeting |
| 04/12/2023 10:30 pm | American Epilepsy Society Meeting - Poster number: 3.270 |
| 04/12/2023 10:30 pm | American Epilepsy Society Meeting - Poster number: 3.261 |
| 04/12/2023 10:30 pm | American Epilepsy Society Meeting - Poster number: 3.269 |
| 01/12/2023 12:15 am | Evercore ISI HealthCONx Conference - Fireside Chat |
| 30/11/2023 12:00 am | Piper Sandler Healthcare Conference - Fireside Chat |
| 08/11/2023 01:00 am | Guggenheim Securities Inflammation & Immunology Conference - Fireside Chat |
| 03/11/2023 01:31 am | Q3 2023 Earnings Release |
| 11/10/2023 07:00 pm | Investor & Analyst Day |
| 28/09/2023 07:15 pm | Cantor Global Healthcare Conference |
| 12/09/2023 06:00 pm | H.C. Wainwright Global Investment Conference |
| 11/09/2023 | American College of Clinical Pharmacology Meeting |
| 07/09/2023 | Citi BioPharma Conference |
| 05/09/2023 06:30 pm | International Epilepsy Congress - 5-HT2C Agonist (#749) |
| 05/09/2023 06:30 pm | International Epilepsy Congress - A 5-HT2C Superagonist (#754) |
| 05/09/2023 06:30 pm | International Epilepsy Congress - Epileptic Encephalopathies (#758) |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 2,50 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -27,8 -27,3 -2.08% | -44,8 -45,7 1.95% | -56,8 -55,1 -2.98% | -81,9 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -27,8 -26,4 -5.33% | -44,8 -45,8 2.27% | -56,8 -56,3 -0.76% | -77,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -27,8 -26,0 -7.08% | -43,9 -45,3 2.91% | -54,4 -54,4 -0.02% | -73,9 |
|
Net income Million USD | Released Forecast Spread | -14,4 | -27,8 -26,0 -7.08% | -43,9 -45,3 3.07% | -54,4 -54,4 -0.02% | -73,9 |
|
EPS USD | Released Forecast Spread | -5,22 | -1,93 -1,80 -7.22% | -2,56 -2,59 1.01% | -2,39 -2,41 0.67% | -2,12 |
| Announcement Date | 19/02/21 | 03/03/22 | 02/03/23 | 12/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 2,50 | 0,00 | |
|
EBITDA Million USD | Released Forecast Spread | -9,62 -9,50 -1.25% | -11,6 -9,50 -21.74% | -11,9 -10,7 -11.06% | -11,7 -12,0 2.28% | -12,0 -12,8 6.55% | -15,6 -12,3 -27.15% | -13,6 -16,0 15.12% | -15,6 -13,9 -11.87% | -15,7 | -16,8 | -18,2 | -19,5 | ||
|
EBIT Million USD | Released Forecast Spread | -8,79 -7,10 -23.86% | -9,62 -9,30 -3.44% | -11,6 -9,85 -17.43% | -11,9 -11,4 -4.02% | -11,7 -12,7 7.39% | -12,0 -13,2 9.21% | -15,6 -13,3 -17.51% | -13,6 -16,4 17.35% | -15,6 -15,2 -2.66% | -16,4 | -17,7 | -19,2 | -20,6 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -8,77 -6,95 -26.28% | -9,60 -9,10 -5.46% | -11,4 -9,50 -20.07% | -11,6 -11,0 -5.74% | -11,3 -12,7 10.4% | -11,5 -13,2 12.88% | -15,0 -13,2 -13.23% | -12,9 -16,4 21.13% | -15,0 -15,0 -0.35% | -15,9 | -16,4 | -18,0 | -19,4 | |
|
Net income Million USD | Released Forecast Spread | -8,77 -6,95 -26.28% | -9,60 -9,10 -5.46% | -11,4 -9,50 -20.07% | -11,6 -11,0 -5.74% | -11,3 -12,7 10.4% | -11,5 -13,2 12.88% | -15,0 -13,2 -13.23% | -12,9 -16,4 21.13% | -15,0 -15,0 -0.35% | -15,9 | -16,4 | -18,0 | -19,4 | |
|
EPS USD | Released Forecast Spread | -0,52 -0,40 -30% | -0,56 -0,49 -14.29% | -0,67 -0,54 -23.31% | -0,68 -0,57 -19.3% | -0,66 -0,68 2.94% | -0,56 -0,57 1.75% | -0,65 -0,60 -9.06% | -0,55 -0,70 21.43% | -0,62 -0,60 -4.17% | -0,49 | -0,48 | -0,46 | -0,57 | -0,57 |
| Announcement Date | 03/03/22 | 05/05/22 | 04/08/22 | 03/11/22 | 02/03/23 | 09/05/23 | 03/08/23 | 02/11/23 | 12/03/24 | - | - | - | - | - |
More events
Past sector events for Longboard Pharmaceuticals, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- LBPH Stock
- Calendar Longboard Pharmaceuticals, Inc.
